Literature DB >> 17943878

Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions.

M Terplan1, S Lui.   

Abstract

BACKGROUND: Illicit drug use in pregnancy is a complex social and public health problem. It is important to develop and evaluate effective treatments. There is evidence for the effectiveness of psychosocial in this population; however, to our knowledge, no systematic review on the subject has been undertaken.
OBJECTIVES: To evaluate the effectiveness of psychosocial interventions in pregnant women enrolled in illicit drug treatment programs on birth and neonatal outcomes, on attendance and retention in treatment, as well as on maternal and neonatal drug abstinence. In short, do psychosocial interventions translate into less illicit drug use, greater abstinence, better birth outcomes, or greater clinic attendance.? SEARCH STRATEGY: We searched the Cochrane Drugs and Alcohol Group's trial register (May 2006), the Cochrane Central Register of Trials (Central- The Cochrane Library, Issue 3, 2005); MEDLINE (1.1996-8.2006); EMBASE (1.1996-8.2006); CINAHL (1.1982-8.2006), and reference lists of articles. SELECTION CRITERIA: Randomised studies comparing any psychosocial intervention versus pharmacological interventions or placebo or non-intervention or another psychosocial intervention for treating illicit drug use in pregnancy. DATA COLLECTION AND ANALYSIS: Two reviewers independently assessed trial quality and extracted data. MAIN
RESULTS: Nine trials involving 546 pregnant women were included. Five studies considered contingency management (CM), and four studies considered manual based interventions such as motivational interviewing (MI). The main finding was that contingency management led to better study retention. There was only minimal effect of CM on illicit drug abstinence. In contrast, motivational interviewing led towards poorer study retention, although this did not approach statistical significance. For both, no difference in birth or neonatal outcomes was found, but this was an outcome rarely captured in the studies. AUTHORS'
CONCLUSIONS: The present evidence suggests that CM strategies are effective in improving retention of pregnant women in illicit drug treatment programs as well as in transiently reducing illicit drug use. There is insufficient evidence to support the use of MI. Overall the available evidence has low numbers and, therefore, it is impossible to accurately assess the effect of psychosocial interventions on obstetrical and neonatal outcomes. It is important to develop a better evidence base to evaluate psychosocial modalities of treatment in this important population.

Entities:  

Mesh:

Year:  2007        PMID: 17943878     DOI: 10.1002/14651858.CD006037.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  13 in total

Review 1.  Contingency management treatment for substance use disorders: How far has it come, and where does it need to go?

Authors:  Nancy M Petry; Sheila M Alessi; Todd A Olmstead; Carla J Rash; Kristyn Zajac
Journal:  Psychol Addict Behav       Date:  2017-06-22

2.  Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates?

Authors:  Annemarie Unger; Reinhold Jagsch; Andjela Bäwert; Bernadette Winklbaur; Klaudia Rohrmeister; Peter R Martin; Mara Coyle; Gabriele Fischer
Journal:  Gend Med       Date:  2011-11-15

3.  Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.

Authors:  Annemarie Unger; Reinhold Jagsch; Hendree Jones; Amelia Arria; Harald Leitich; Klaudia Rohrmeister; Constantin Aschauer; Berndadette Winklbaur; Andjela Bäwert; Gabriele Fischer
Journal:  Addiction       Date:  2011-05-12       Impact factor: 6.526

Review 4.  Treatment of cocaine abuse during pregnancy: translating research to clinical practice.

Authors:  Lynn Hull; James May; Dawn Farrell-Moore; Dace S Svikis
Journal:  Curr Psychiatry Rep       Date:  2010-10       Impact factor: 5.285

5.  The efficacy of escalating and fixed contingency management reinforcement on illicit drug use in opioid-dependent pregnant women.

Authors:  Melissa L Hutchinson; Margaret S Chisolm; Michelle Tuten; Jeannie-Marie S Leoutsakos; Hendrée E Jones
Journal:  Addict Disord Their Treat       Date:  2012-09

6.  Incentives for retention of pregnant substance users: a secondary analysis.

Authors:  Gregory Brigham; Theresa Winhusen; Daniel Lewis; Frankie Kropp
Journal:  J Subst Abuse Treat       Date:  2009-07-03

7.  Gender Considerations in Addiction: Implications for Treatment.

Authors:  Kathryn Polak; Nancy A Haug; Haroldo E Drachenberg; Dace S Svikis
Journal:  Curr Treat Options Psychiatry       Date:  2015-09

8.  Characteristics of perinatal women seeking treatment for marijuana abuse in a community-based clinic.

Authors:  Golfo Tzilos; Lynn Hess; Jennifer Chien-Wen Kao; Caron Zlotnick
Journal:  Arch Womens Ment Health       Date:  2013-06-05       Impact factor: 3.633

Review 9.  Pharmacologic interventions for pregnant women enrolled in alcohol treatment.

Authors:  Erica J Smith; Steve Lui; Mishka Terplan
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery.

Authors:  Kimberly A Yonkers; Ariadna Forray; Heather B Howell; Nathan Gotman; Trace Kershaw; Bruce J Rounsaville; Kathleen M Carroll
Journal:  Gen Hosp Psychiatry       Date:  2012-07-12       Impact factor: 3.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.